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IGF-tIJMan-6-P receptors in rat kidney: Apical localization in proximal
tubule cells. The present study was performed to determine the local-
ization of insulin-like growth factor II (IGF-I1) binding in the rat
nephron and, furthermore, to determine directly the distribution of the
IGF-II/Man-6-P receptor in the proximal tubule. The IGF-II/Man-6-P
receptor was visualized by immunohisto- and cytochemical techniques,
and the binding of IGF-11 was shown by light and electron microscope
autoradiography applying '251-IGF-II directly on cryosections. The
tubular uptake of IGF-II was studied by autoradiography after in vivo
injection of '251-IGF-II. The light microscope immunolabeing was
confined to a relatively narrow band in the apical part of the proximal
tubule cells just below the brush border, and was strongest in the first
portion of the proximal tubule, segment 1 (Sl), with decreasing inten-
sity in segment 2 (S2) and weaker in segment 3 (S3). Several cytoplas-
mic bodies were labeled but no label was observed in the basolateral
part of the cells. We did not detect any labeling of glomeruli or other
segments of the nephron. Electron microscope immunocytochemistry
in the proximal tubule revealed a strong labeling in apical endocytic
invaginations, small endocytic vacuoles, and large endocytic vacuoles,
weaker in lysosomes and dense apical tubules. Light microscope
autoradiography after incubation of cryosections with labeled IGF-II
demonstrated an intense labeling just beneath the brush border, espe-
cially in Sl of the proximal tubule, and, in addition, the corresponding
electron microscope autoradiography revealed an intense labeling over
large endocytic vacuoles and lysosomes. These results were confirmed
and extended by competitive binding experiments and quantitative
immunocytochemistry. After i.v. injection of '251-IGF-II autoradio-
graphic grains were almost exclusively observed in the electronmicro-
scope over endocytic vacuoles and lysosomes in the Sl of the proximal
tubule. The present study shows that the IGF-II/Man-6-P receptor is
located in components of the vacuolar system in the apical cytoplasm of
rat renal proximal convoluted tubule cells, mainly in Si. This localiza-
tion was seen to be consistent using various immunolabeling and
autoradiographic techniques in vivo and in vitro.
Insulin-like growth factor II (IGF-II) is a polypeptide (molec-
ular wt 7,500) with partial structural homology with both insulin
and insulin-like growth factor I (IGF-I) [1]. IGF-II is produced
in a number of tissues and the production is probably less
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GH-dependent than IGF-I production [2]. It has also been
suggested that IGFs produced in tissues may act as local growth
factors by autocrine or paracrine action [3, 41.
The IGF-II/Man-6-P receptor is structurally unrelated to the
IGF-I and insulin receptors, and consists of a single chain (Mr
= 220 kDa) transmembrane glycoprotein without tyrosine-
kinase activity [5, 6]. Morgan et al [6] demonstrated that the
amino acid sequence of the human IGF-II receptor is 80%
homologous to the bovine cationic mannose-6-phosphate recep-
tor, and later biochemical studies have supported this homology
[7]. The IGFs bind to cell surface receptors on a variety of
target cells and cause both metabolic effects and changes in the
rate of protein synthesis and growth [8]. IGF-I also binds to the
IGF-II/Man-6-P receptor, but with much lower affinity than
IGF-II, while the IGF-II/Man-6-P receptor does not bind insulin
at all [5].
Previous studies have described the existence of IGF-II/Man-
6-P receptors in the plasma membrane of a variety of different
cell types, including renal glomeruli and tubules [9, 10]; further-
more, mRNA expression for IGF-II/Man-6-P receptors has
been shown in kidney tissue [11]. In the renal proximal tubule
the IGF-IIIMan-6-P receptor has been characterized both in the
brush border and basolateral membrane vesicle fractions [10],
and the relative distribution was reported to be symmetrical
[10]. A physiological effect from activated IGF-II/Man-6-P
receptors in the luminal membranes in the proximal tubule has
not been demonstrated. Effects such as phospholipase C acti-
vation and stimulation of Na-H exchange in proximal tubules
have been ascribed to action from basolateral receptors [12, 13].
Receptors from renal basolateral membranes have been shown
to be activated by mannose-6-phosphate containing peptides in
addition to activation by IGF-II [14].
The aim of the present study was to describe the distribution
of the IGF-II/Man-6-P receptor in the rat kidney, both with
respect to localization in the different segments of the nephron
and to the exact cellular localization. In this study a very
consistent localization of the IGF-II/Man-6-P receptor in rat
kidney was observed using several different techniques: immu-
nohisto- and cytochemistry for localization of the receptor and
autoradiography at the light and electron microscope levels in
vivo and in vitro for localization of IGF-II binding. We report
here that the IGF-II/Man-6-P receptor is localized in the apical
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part and in cytoplasmic bodies in rat kidney proximal tubule
cells.
Methods
Animals
Male Wistar rats (MØllegaard Avlslab., Eiby, Denmark),
weighing between 240 and 300 grams, were used for all exper-
iments.
Antibody
In the present study a specific rabbit anti-rat IGF-II/Man-6-P
receptor antiserum 3637 [15] was used for immunohistochem-
istry and immunoblotting. This antiserum does not cross react
with the IGF-I or insulin receptors, nor does it recognize IGF
binding proteins or the cation-dependent Man-6-P receptor [7,
151. For preabsorption control experiments, rat IGF-II/Man-6-P
receptor was purified from livers of 150 g Sprague-Dawley rats.
Livers were homogenized and a plasma membrane preparation
was obtained by differential ultracentrifugation. The microso-
mal membrane fraction was solubilized in 1% Triton-X 100. The
solubilized plasma membranes were incubated with a beta-
galactosidase-Sepharose affinity column, and IGF-II/M-6-P re-
ceptors were eluted from the column after one hour of incuba-
tion of the column with 10 mi M-6-P [7]. Protein content in the
receptor preparation was measured using Pierce BCA assay
(Pierce Chemical Co, Rockford, Illinois, USA; Catalog no.
23225).
Immunoblotting
Renal cortical tissue from rats, 100 mg aliquots were homog-
enized, solubilized in 1 ml 1% Triton X-lOO in 20 mM Tris, 150
mM NaCl and 1 m phenylmethanosuffonyl fluoride and cen-
trifuged for two minutes in an Eppendorf centrifuge. From the
supernatant 20 sl was applied to a sodium dodecyl sulfonate gel
with a 4 to 16% polyacrylamide gradient, electroblotted for 1.5
hours at 0.2 amps onto an Immobilon filter (Millipore). The filter
was blocked for two hours in 2% nonfat dry milk, incubated for
two hours with the IGF-II/Man-6-P antibody diluted 1:1000 in
0.2% nonfat dry milk, washed 3 x 15 minutes in PBS with
0.05% Tween-20, incubated with alkaline phosphatase conju-
gated anti-rabbit antibody (Dako AIS, Glostrup, Denmark) in a
1:2000 dilution in 0.2% nonfat dry milk, and finally washed.
Staining was visualized using 5-bromo-4-chloro-3-indolyl-phos-
phate (0.125 mg/mI) and Nitro Blue Tetrazolium (0.25 mg/mI) as
substrate.
Tracers and peptides
[3-(1251)iodotyrosyl] IGF-II with a specific activity of 2,000
Ci/mmol (purchased from Amersham International, Amersham,
Bucks, UK) or human '251-IGF-II (400 Ci/mmol) labeled by the
chloramine-T method was used in all autoradiographic experi-
ments. Unlabeled biosynthetical IGF-I and IGF-II were pur-
chased from Bachem (Bubendorf, Switzerland), while unla-
beled porcine insulin was provided by Novo Nordisk A/S
(Bagsvrd, Denmark). Cytochrome C and lysozyme were
purchased from Sigma Chemical Co.
Immunohistochemistry and immunocytochemist,y
The rats for immunohisto- or immunocytochemistry studies
were anaesthetized i.p. with sodium pentobarbital (65 mg/kg
body wt), and the kidneys were fixed by retrograde perfusion
through the abdominal aorta with 8% paraformaldehyde in 0.15
M sodium cacodylate buffer, pH 7.2. Then tissue blocks from
cortex, outer and inner medulla were further fixed by immer-
sion in the same fixative for one hour, immersed for 30 minutes
in 2.3 M sucrose containing 2% paraformaldehyde, and finally
frozen in liquid nitrogen.
Sections were obtained by cryoultramicrotomy using a Re-
ichert-Jung FC 4D cryoultramicrotome at 160 to 180 K. For
light microscopy 0.80 m sections were placed on gelatin-
coated glass slides. For electron microscopy 85 nm sections
were placed on 300 mesh Ni-grids. All sections were preincu-
bated in PBS containing 0.1% to 0.3% nonfat dry milk and 0.05
M glycine, except the sections for immunofluorescence which
were preincubated in PBS containing 0.1% gelatin, 0.5% BSA
and 0.02 M glycine.
For immunolabeling, the sections were incubated with the
primary antibody (IGF-II/Man-6-P-receptor antibody) at 4°C
overnight at different dilutions (1:50 to 1:150) in the same buffer
as described above but without glycine, and then washed in the
same buffer. For light microscopy, the sections were incubated
either with FITC-conjugated swine anti-rabbit immunoglobulins
for immunofluorescence (Dako) or with peroxidase-conjugated
affinity-isolated goat anti-rabbit immunoglobulins for immuno-
histochemistry (Dako). The peroxidase was visualized with
diaminobenzidine (10 mm incubation) and the sections were
washed. For electron microscopy, the sections were incubated
for two hours at 4°C with 5 nm goat anti-rabbit gold. The
sections for electron microscopy were finally covered with 2%
methylcellulose containing 0.3% uranyl acetate as described by
Tokuyasu [16] and modified by Griffiths et al [17].
For quantitative analysis of immunocytochemical localiza-
tion of IGF-II/Man-6-P receptors, proximal tubules were pho-
tographed at random at a primary magnification of x20,000 and
enlarged to a final magnification of x 60,000. Gold particles were
counted over the different organelles in the cells, and the areas
of the same regions were determined by point counting [18]
using a lattice square test system with a distance between lines
of 25 mm corresponding to 0.42 m. The values were expressed
as a percentage of the total area of the cells analyzed.
For immunolabeling, the following controls were performed:
(1.) incubation with a nonspecific rabbit serum (Dako); (2.)
incubation with the specific antibody, diluted 1:150, preab-
sorbed with purified receptor (see above), 6 mg/mI; (3.) without
primary antibody; and (4.) without primary and secondary
antibodies.
In vitro incubation of sections with '251-IGF-II
For autoradiography, sections were incubated with 125j
labeled IGF-II (about 1 Ci/m1) either alone or together with
different proteins for competitive binding studies (unlabeled
IGF-II, IGF-I, insulin, cytochrome C and lysozyme) at varying
concentrations diluted in PBS buffer containing 0.1% nonfat dry
milk. The sections were washed and subsequently fixed in 1%
glutaraldehyde in 0.1 M sodium cacodylate buffers, pH 7.2, for
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10 minutes and then washed. For light microscope autoradio-
graphy the sections were dipped in LM- 1 emulsion (Amer-
sham), exposed for one to two weeks, developed in Kodak D19
developer, fixed in sodium thiosulphate, and subsequently
stained with toluidine blue. For electron microscope autora-
diography the sections were covered with 2% methylcellulose
containing 0.3% uranyl acetate as described above and then
coated with carbon. Autoradiographic emulsion (Ilford L4) was
applied by a modified wire loop method [19], exposed for one to
two weeks, developed in Kodak D19, and fixed in sodium
thiosulphate.
Preparation of renal tissue after i.v. injection of '251-IGF-II
Rats anaesthetized i.p. with sodium pentobarbital (65 mg/kg
of body wt) were injected in the femoral vein with 1 ml of
'251-labeled IGF-II (40 MCi) with a specific activity of 400
Ci/mmol. Five minutes after injection the kidneys were fixed by
perfusion as above with 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer, pH 7.3, further fixed by immersion in the
same fixative for a minimum of 12 hours, and postfixed in 1%
0s04 for 60 minutes. Subsequently the tissue was dehydrated in
graded alcohols (70, 90, 96, and 99%) and embedded in Epon
812 in fiat molds.
Thin sections were cut on an LKB Ultrotome III, mounted on
100 mesh copper grids and stained with lead citrate and uranyl
acetate. Ilford L4 emulsion was applied to the grids as de-
scribed above, developed in Kodak D 19 (90 seconds, 20°C) and
fixed in a 20% sodium thiosulphate solution for 120 seconds.
Microscopy
The FITC-labeled sections were studied in a Zeiss Axiophot
microscope, the peroxidase labeled sections in a Leitz ortho-
plane microscope, and the electron microscope sections in a
JEOL 100 CX electron microscope.
Results
Immunoblotting
The immunoblots demonstrated labeling of only one band
with an apparent molecular weight of 220 to 250 kDa corre-
sponding to the IGF-II/Man-6-P receptor (Fig. 1), as previously
shown [7, 9, 15].
Immunohistochemistry
Immunolabeling for the IGF-II/Man-6-P receptor was ob-
served only in the presence of the specific antibody and was
confined to a narrow band in the apical part of the proximal
tubule cells just below the brush border as revealed both by
immunoperoxidase (Fig. 2) and immunofluorescence (Fig. 3 a
and b). In addition, cytoplasmic bodies were labeled in the
proximal tubule, especially in segments 1 and 2 (Figs. 2 and 3).
The labeling in segment 3 was weaker than that in segments 1
and 2 (Fig. 3 a and b). It should be emphasized that no labeling
was observed in the brush border or the basolateral parts of the
proximal tubule cells. Furthermore, we observed no labeling in
the glomeruli, in other segments of the nephron, or in the
collecting duct system (Figs. 2 and 3).
Fig. 1. Immunoblot of homogenate from rat renal cortex using the
anti-IGF-II receptor serum. The stained protein band had a molecular
weight of about 220,000 to 250,000 under non-reducing conditions
corresponding to the IGF-II/Man-6-P receptor, Molecular weight mark-
ers are a2-macroglobulin receptor (nonreduced 500 kDa), a2-macro-
globulin (reduced 180 kDa), phosphorylase b (reduced 94 kDa) and
albumin (reduced 67 kDa).
Light microscope autoradiography
Cryosections incubated with '251-labeled IGF-II revealed a
significant labeling of cross sections of proximal tubules. Cryo-
sections obtained from the juxtamedullary part of cortex dem-
onstrated an intense labeling in segment 1 (Sl) with decreasing
intensity in segment 2 (S2) and weaker in segment 3 (S3) (Fig. 4
a and b). The label was confined mainly to the apical part of the
proximal tubule cells just below the brush border and there was
no labeling of the brush border. In addition to the apical labeling
of especially segment 1 (Fig. Sa) there was a certain cytoplasmic
labeling. No other parts of the nephron or the glomeruli showed
any specific labeling.
In competitive binding experiments the apical binding of
1251.IGF4I was totally inhibited by unlabeled IGF-II at a
concentration of 10—6 M, while at the same concentration of
unlabeled IGF-I there was still a little labeling left (Figs. 5 b—d).
At a concentration of l0 M of unlabeled IGF-I there was no
reaction left and thus IGF-I was more than 10 times less
effective than IGF-II in blocking the '251-IGF-II binding. Insulin
at concentrations up to 10 M did not inhibit binding of
'251-IGF-II, nor did cytochrome C or lysozyme at similar
concentrations.
Immunocytochemistry
In general the immunogold-labeling of the proximal tubules
was most intense over Sl, decreasing in S2, and relatively
weaker in S3. In all segments of the proximal tubules, the apical
endocytic invaginations, small and large endocytic vacuoles
were labeled with gold particles (Fig. 6 a and b). Lysosome-like
bodies, dense apical tubules and brush border showed less
labeling and almost no labeling was observed over nuclei and
mitochondria. No significant labeling was observed in other
parts of the nephron.
A semiquantitation of the distribution of IGF-II/Man-6-P
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Fig. 2. Immunoperoxidase staining (antiserum 3637, 1:100) for IGF-II/Man-6-P receptors is seen as a narrow band in the apical part of the
proximal tubules (P)just below the brush border (arrow). Cytoplasmic bodies (arrowheads) in proximal tubules are also labeled. No labeling is seen
in the basal part of the proximal tubule cells corresponding to the basolateral membranes. Furthermore, glomeruli (G), distal tubules (D), and
collecting ducts (C) are not labeled. x 550. B. Immunoperoxidase staining (antiserum 3637, 1:150) of proximal tubules at higher magnification. The
staining is again seen as a narrow bond just below the brush border. The staining of cytoplasmic bodies often appears as ring-like structures
(arrows). xl ,200. C. Absorption control (antiserum 3637, 1:150, preabsorbed with purified receptor, 6mg/mi) of parallel section to B. Only a weak
staining is seen below the brush border and the staining of the cytoplasmic bodies has almost disappeared. xl ,200. D. Incubation with non-immune
serum 1:150. Parallel section to B and C. A very weak staining is seen below the brush border and no cytoplasmic staining is seen. x 1,200.
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Fig. 3. Immunofluorescence micrographs (antiserum 3637, 1:100) showing a narrow band corresponding to IGF-lI/Man-6-P receptors in the
apical part of proximal tubules. No labeling of the basolateral membranes is seen. A. Micrograph from cortex demonstrating labeling of
cytoplasmic bodies besides the apical labeling of the renal proximal convoluted (P) tubules, segments 1 and 2. No labeling is seen in glomeruli (G).
x490. B. Micrograph from outer medulla. The labeling found in the proximal tubules (segment 3, S3) is weaker than that seen in segment I and
segment 2 in A. Also the labeling of cytoplasmic bodies is more sparse. x640.
receptors in the proximal tubule is shown in Table 1. The
highest density of gold particles was seen in the apical part of
the cells, over endocytic invaginations, small endocytic vacu-
oles and large endocytic vacuoles. Also an accumulation was
observed in lysosomes and over the brush border, whereas the
relative density over the mitochondria, nuclei and cytoplasm
was less than 1.
Electron microscope autoradiography in vitro
Large endocytic vacuoles which had an electron-lucent inte-
nor were occasionally heavily labeled, and so was the apical
part of the cytoplasm probably corresponding to endocytic
invaginations and small endocytic vacuoles (Fig. 7 a and b). In
many cells of the proximal tubule the lysosome-like bodies
identified by their electron dense appearance were heavily
labeled with grains (Fig. 7c). However, there was also a low
apparent unspecific background labeling over the cytoplasm.
Electron microscope autoradiography after i.v. injection of
'2511GF11
Autoradiographic grains were found exclusively over the
proximal tubules. The vast majority of the grains appeared in
the first segment of the proximal tubule. The labeling was much
less pronounced in the second and third segments of the
proximal tubule, S2 and S3. The grains in all segments of the
proximal tubule were mainly located over small and large
endocytic vacuoles, dense apical tubules, and lysosomes (Fig.
8). There was no labeling over any other part of the cells.
Discussion
In the present study we determined the localization of IGF-
II/Man-6-P receptors in rat renal proximal tubules by means of
immunohistochemical, immunocytochemical, and autoradio-
graphic techniques in vivo and in vitro. There was a high degree
of consistency between the different methods regarding local-
ization of the IGF-II/Man-6-P receptors in the nephron both at
cellular and subcellular levels. The binding sites were confined
to components of the vacuolar system related to endocytosis in
the apical part of proximal tubule cells. Furthermore, the
labeling intensity of both the immunolocalization of the recep-
tor and the specific binding of IGF-II was highest in segment 1,
lower in segment 2 and lowest in segment 3. There was no
detectable labeling of basolateral membranes in proximal tu-
bules and no labeling in other parts of the nephron was
observed.
The IGF-II/Man-6-P receptor binds IGF-II with high affinity,
IGF-I with a lower affinity and does not bind insulin at all [5]. In
our competitive binding experiments the '251-IGF-II binding
was almost completely inhibited by unlabeled IGF-II. The
binding was also to a high extent inhibited by unlabeled IGF-I,
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Fig. 4. Light microscope autoradio graphs of cryosections
incubated in vitro with '251-IGF-II from the juxtamedullary part of
cortex (A) and Outer cortex (B). In A strong apical labeling is seen
in segment 1 (Si), weaker if any in segment 2 (S2), and segment 3
(S3). No specific labeling is seen in collecting duct (C). Low level
of background is seen over cytoplasm and nucleus. x490. B.
Labeling is predominantly seen in Si. No labeling is seen in
glomeruli (G) and distal tubules (D). Segment 1 (SI), Segment 2
(S2), x500.
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Fig. 5. Light microscope autoradiography of cryosections from Outer cortex incubated in vitro with '251-IGF-1I. Observe that B, C and Dare from
neighboring sections. During incubation 10—6 M cold IGF-I was added to C, and 1O_6 M cold IGF-II to D. A. Labeling is seen very heavily
concentrated in the initial part of the proximal tubule (Si), here seen connected to the Bowman's capsule (arrows). x750. B. Heavy labeling is seen
in segment 1 (Si), especially just below the brush border (arrows); only weak labeling is seen in S2. No specific labeling is observed in connecting
tubules (CT). x750. C. The labeling has extensively decreased in Si, although, a little labeling is still seen (arrows). x750. D. The labeling has
almost disappeared, x750.
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Fig. 6. Ultrathin cryosections of the renal proximal tubules immunolabeled for IGF-II/Man-6-P receptor using protein A-gold (5 nm). A. Gold
particles are found in the apical part of the renal proximal tubule cells mainly in invaginations (IN) and small endocytic vacuoles (SEV). Microvilli
(MV). x60,000. B. Labeling is seen in large endocytic vacuole (LEV), invaginations (IN) and dense apical tubules (DAT). x75,000.
Table 1. Distribution of IGF-II/Man-6-P receptors in rat renal proximal tubul&'
CYT MIT NUC LEY SEV IN LY DAT BB Total
Gold particles, no. 444 537 529 451 406 751 83 146 739 4086
Gold particles, % 10.9 13.1 12.9 11.0 10.0 18.4 2.0 3.6 18.1
% Area 41.5 13.9 22.6 3.6 1.9 3.8 0.9 3.0 8.7
Relative densityb 0.26 0.94 0.57 3.1 5.3 4.8 2.2 1.2 2.1
% gold/% area
Abbreviations are: CYT, cytoplasm; MIT, mitochondria; NUC, nucleus; LEY, large endocytic vacuoles; SEV, small endocytic vacuoles; LY,
lysosomes; DAT, dense apical tubules; BB, brush border.
a Total cell area examined constituted 1003 m2.
' Relative density was calculated as percentage gold particles divided by percentage area of the different cell organelles.
but not inhibited by insulin, cytochrome C or lysozyme. Thus
the competition experiments further substantiated that the
receptors, which were demonstrated in this study to be distrib-
uted over the apical part of the proximal tubule cells, were
authentic type II IGF receptors rather than other types of
receptors (that is, insulin or type I IGF receptor) or scavenger
receptors for endocytic reabsorption of proteins in the proximal
tubule. The limited cellular labeling seen in the light micro-
scopic autoradiography was, at least in part, due to late
endosome/pre-lysosomal labeling as revealed by the electron
microscopic autoradiography (Fig. 7c).
The IGF-II/Man-6-P receptor has been localized and charac-
terized in many tissues in various species, including humans
[21]. With the increasing interest regarding the role of growth
hormones including IOF-Il in renal physiology and pathophys-
iology [reviewed in 20], a detailed knowledge of the sites of
IGF-II binding in the kidney seems pertinent. However, only
few studies have focused on the renal distribution of the
IGF-II/Man-6-P receptor. Various localizations have been sug-
gested for the IGF-II/Man-6-P receptors in the kidney in previ-
ous studies, such as glomeruli [9, 21] and proximal tubules [10,
21, 22]. Investigations using immunohistochemical techniques
demonstrated IGF-II/Man-6-P receptors on the inner surface of
renal tubules and on Bowman's capsule of the glomeruli [21].
Studies carried out using isolated basolateral and brush
border membrane fractions have shown that the distribution of
IGF-II/Man-6-P receptors between basolateral and brush bor-
der membranes was largely symmetrical [10] [reviewed in 20].
IGF-I receptors, in contrast, were shown to be asymmetrically
distributed being predominantly basolateral [10]. In the present
study using different techniques, IGF-II/Man-6-P receptors and
binding sites were observed only in the apical part of the
4
pva
B
F
LEV
I
804 Cut et at: IGF-!I receptors in rat kidney
Fig. 7. A. Electron microscope autoradiograph of proximal tubule cells from ultrathin cryosections incubated with '251-IGF-II. Autoradiographic
grains are located over the apical part of the proximal tubule cell. Large endocytic vacuoles (LEV), microvilli (MV), and mitochondria (MI).
x27,000 B. Demonstration of autoradiographic grains heavily concentrated over large endocytic vacuole (LEV). X 17,000 C. Autoradiographic
grains located over lysosomes (LY). X 18,000.
proximal tubule cells. The discrepancy between the present
results and the above-cited investigations regarding basolateral
localization of receptors [10] is at present unknown but there
may be different explanations. (1) The reason could reside in
experimental procedures. It is well recognized that cell frac-
tionation methods may suffer from limited cross-contamination
of the different fractions obtained. The contamination can be
expressed, such as the presence of brush border enzymes and
basolateral Na/K-ATPase activity in the different fractions
and appropriate corrections can be made. However, the present
results strongly suggest the presence of the IGF-II/Man-6-P
receptor in membranes of endocytic invaginations as well as in
endocytic vesicles/vacuoles but not in the microvilli of the
brush border. To our knowledge no markers specific for mem-
brane obtained from endocytic invaginations have been de-
scribed and it is possible that membrane material from this
compartment may contaminate basolateral membrane vesicle
fractions as well as brush border membrane vesicle fractions.
As a consequence, it may be difficult to estimate the relative
distribution of membrane proteins such as IGF-II/Man-6-P
receptors located specifically in invaginations and intracellular
vacuoles by techniques involving brush border and basolateral
membrane vesicle fractions. Our results do not necessarily
exclude localization of receptors in basolateral membranes, but
the density is probably considerably lower compared to the
luminal plasma membrane. Indeed, studies performed on iso-
lated segments of proximal tubules suggest that IGF-II stimu-
lated NatH exchange across the brush border membrane and
changes in intracellular pH, and these actions were ascribed to
basolateral receptor action [13]. In addition, IGF-II stimulated
inositol triphosphate production by activation of phospholipase
C [12] was observed only after incubation with basolateral
membrane fractions and not with brush border membrane
vesicles. (2) Hypothetically the luminal and basolateral recep-
tors may be different, thus the used antibody would not
necessarily recognize such a putative IGF-II/Man-6-P receptor
subtype on the basolateral membranes if different from the
recognized luminal counterpart. The immunoblotting (Fig. 1),
however, showed only one band in renal cortical homogenates
with a molecular weight similar to IGF-II/Man-6-P receptors
demonstrated by other investigators in the kidney and other
tissues [7, 9, 15]. The experiments with in vitro incubation of
'251-IGF-II on cryosections clearly demonstrated displaceable
apical binding and no significant basolateral binding. These
binding studies and binding competition studies strongly con-
firm the immunolabeling results, thus, it appears unlikely that
differences in receptor types can explain the discrepancy.
There was a clear dependence of the segmentation of the
proximal tubule on the labeling intensity. By in vitro incubation
of cryo sections with '251-IGF-II, SI segments were labeled in
the apical part of the cells to a high extent but only very little
labeling was confined to S2 and S3 segments. This pattern was
'#4'
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Fig. 8. Electron microscope autoradiograph of proximal tubule Si from rat kidney after iv. injection of'251-IGF-Il. Autoradiographic grains are
located over the apical part of the proximal tubule cells. Endocytic invagination (IN), large endocytic vacuoles (LEV), lysosomes (LY), brush
border (BB). x 15,000.
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also observed by immunocytochemistry and the labeling of S3
was considerably lower than in SI and S2 segments. Autorad-
iographic grains were also almost exclusively concentrated over
Si proximal tubules after in vivo administration of '251-IGF-II.
This may be due to the proportionally larger concentration of
'251-IGF-II in the ultrafiltrate in Si than in S2 and S3 due to
progressive absorption in Si. This pattern is similar to obser-
vations in similar experiments using 1251-insulin [23]. However,
the endocytic uptake may also be reduced in S2 and S3
proximal tubule segments due to the lower density of receptors
in the apical endocytic invaginations in segments 2 and 3 as
observed in the present study. The tubular fluid in the proximal
tubule S2 and S3 segments probably contain at least small
amounts of IGF-II that escaped absorption in Si, since IGF-II
has been determined in significant amounts in the urine [241.
After i.v. injection of '251-IGF-II, the protein was internalized
by endocytosis in the proximal tubules. 1251-IGF-II was con-
centrated in the vacuolar apparatus including the lysosomes in
the apical part of proximal tubules representing receptor medi-
ated internalization of the hormone to be degraded in the
proximal tubules. Receptor mediated internalization of IGF-II
has also been described in other cell types [15, 251. The
concentration of circulating IGF-II in adult rats is significantly
lower than in newborn rats but is still about 40 ng/ml [26]. Thus
the localization of the receptor in endocytic invaginations of
proximal tubules may serve to remove IGF-II efficiently from
the tubular fluid and also possibly IGF-I although with a lower
efficiency due to the lower affinity of IGF-I to the IGF-II
receptor. With respect to specificity of protein reabsorption in
renal proximal tubule cells we have recently shown that gp330,
which is located in apical endocytic invaginations and vacuoles
in renal proximal tubules [27], functions as a receptor for
a2-macroglobulin receptor associated protein (a2MRAP) [28].
The intracellular localization of the receptor in endocytic
vesicles and vacuoles but also in lysosome-like bodies probably
to a high extent reflects that this receptor also functions as
Man-6-P receptor. Lysosome-like bodies with an electron dense
appearance were heavily labeled with grains (Fig. 7c) after in
vitro incubation on cryosections indicating that these are pre-
lysosomes or primary lysosomes characterized by the presence
of Man-6-P receptors [29]. The method presented in this study
with direct labeling of IGF-II on ultrathin cryosections can thus
be used for the identification of prelysosomes and late endo-
somes.
The localization of IGF-II/Man-6-P receptors in endocytic
invaginations, endocytic vesicles, vacuoles, and in dense apical
tubules, combined with the rapid internalization and intracellu-
lar processing of '251-IGF-II into lysosomes, raise the possibil-
ity of rapid IGF-II/Man-6-P receptor cycling between the cell
surface and components of the vacuolar systems. Thus, the
receptor probably follows the endocytic and recycling pathway
for membrane constituents as previously described [30] and
recently reviewed [31, 32].
In conclusion, the present study strongly suggests that IGF-
IIIMan-6-P receptors are located in the apical plasma membrane
in endocytic invaginations in the proximal tubule but we cannot
totally exclude the presence of small amounts in the basolateral
membranes and/or glomeruli.
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